Ines Ushiro-Lumb, United Kingdom Screening is not the limit
Matthew Roberts, Australia The potentially infected donor. Why decline if it can be managed?
Mr. Juntaro Ashikari, Japan HTLV-1 screening in organ donation: Perspectives from an endemic country
Dr. Mario Royo-Villanova, Spain Utilization from patient with cerebral tumor
